<VariationArchive VariationID="188910" VariationName="NM_000466.3(PEX1):c.782_783del (p.Gln261fs)" VariationType="Deletion" Accession="VCV000188910" Version="23" RecordType="classified" NumberOfSubmissions="9" NumberOfSubmitters="8" DateLastUpdated="2024-06-17" DateCreated="2015-03-29" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="186758" VariationID="188910">
      <GeneList>
        <Gene Symbol="PEX1" FullName="peroxisomal biogenesis factor 1" GeneID="5189" HGNC_ID="HGNC:8850" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7q21.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="92487025" stop="92528520" display_start="92487025" display_stop="92528520" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="92116336" stop="92157844" display_start="92116336" display_stop="92157844" Strand="-" />
          </Location>
          <OMIM>602136</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000466.3(PEX1):c.782_783del (p.Gln261fs)</Name>
      <CanonicalSPDI>NC_000007.14:92517731:TT:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7q21.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="92517732" stop="92517733" display_start="92517732" display_stop="92517733" variantLength="2" positionVCF="92517731" referenceAlleleVCF="CTT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="92147046" stop="92147047" display_start="92147046" display_stop="92147047" variantLength="2" positionVCF="92147045" referenceAlleleVCF="CTT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>Q261fs</ProteinChange>
      <ProteinChange>Q53fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.92147046_92147047del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.92147046_92147047del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.92517732_92517733del" Assembly="GRCh38">
            <Expression>NC_000007.14:g.92517732_92517733del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008341.2" sequenceAccession="NG_008341" sequenceVersion="2" change="g.15799_15800del">
            <Expression>NG_008341.2:g.15799_15800del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000466.3" sequenceAccession="NM_000466" sequenceVersion="3" change="c.782_783del" MANESelect="true">
            <Expression>NM_000466.3:c.782_783del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000457.1" sequenceAccession="NP_000457" sequenceVersion="1" change="p.Gln261fs">
            <Expression>NP_000457.1:p.Gln261fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282677.2" sequenceAccession="NM_001282677" sequenceVersion="2" change="c.782_783del">
            <Expression>NM_001282677.2:c.782_783del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001269606.1" sequenceAccession="NP_001269606" sequenceVersion="1" change="p.Gln261fs">
            <Expression>NP_001269606.1:p.Gln261fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282678.2" sequenceAccession="NM_001282678" sequenceVersion="2" change="c.158_159del">
            <Expression>NM_001282678.2:c.158_159del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001269607.1" sequenceAccession="NP_001269607" sequenceVersion="1" change="p.Gln53fs">
            <Expression>NP_001269607.1:p.Gln53fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA274114" DB="ClinGen" />
        <XRef Type="rs" ID="749067142" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00001" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00002" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00004" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00004" Source="The Genome Aggregation Database (gnomAD), exomes" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000466.3(PEX1):c.782_783del (p.Gln261fs) AND Peroxisome biogenesis disorder 1A (Zellweger)" Accession="RCV000169270" Version="4">
        <ClassifiedConditionList TraitSetID="551">
          <ClassifiedCondition DB="MedGen" ID="C4721541">Peroxisome biogenesis disorder 1A (Zellweger)</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2014-08-01" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000466.3(PEX1):c.782_783del (p.Gln261fs) AND Zellweger spectrum disorders" Accession="RCV001201363" Version="6">
        <ClassifiedConditionList TraitSetID="55427">
          <ClassifiedCondition DB="MedGen" ID="C0043459">Zellweger spectrum disorders</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-20" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000466.3(PEX1):c.782_783del (p.Gln261fs) AND multiple conditions" Accession="RCV001004520" Version="1">
        <ClassifiedConditionList TraitSetID="10202">
          <ClassifiedCondition DB="MedGen" ID="C4721541">Peroxisome biogenesis disorder 1A (Zellweger)</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0282527">Peroxisome biogenesis disorder 1B</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000466.3(PEX1):c.782_783del (p.Gln261fs) AND Peroxisome biogenesis disorder" Accession="RCV001194278" Version="1">
        <ClassifiedConditionList TraitSetID="7944">
          <ClassifiedCondition DB="MedGen" ID="C1832200">Peroxisome biogenesis disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-01-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000466.3(PEX1):c.782_783del (p.Gln261fs) AND not provided" Accession="RCV001781524" Version="6">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-10-17" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000466.3(PEX1):c.782_783del (p.Gln261fs) AND Inborn genetic diseases" Accession="RCV003162722" Version="2">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-02-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000466.3(PEX1):c.782_783del (p.Gln261fs) AND Heimler syndrome 1" Accession="RCV003474903" Version="2">
        <ClassifiedConditionList TraitSetID="23229">
          <ClassifiedCondition DB="MedGen" ID="C4551980">Heimler syndrome 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-02-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-04" NumberOfSubmissions="9" NumberOfSubmitters="8" DateCreated="2015-03-29" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">19105186</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21031596</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23247051</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">2324705</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26387595</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31831025</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33708531</ID>
        </Citation>
        <DescriptionHistory Dated="2019-08-13">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="10202" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5138" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Zellweger leukodystrophy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Peroxisome biogenesis disorder 1A (Zellweger)</ElementValue>
                <XRef ID="MONDO:0008953" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Peroxisome biogenesis disorder 1a</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PBD1A</ElementValue>
                <XRef Type="MIM" ID="214100" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CHR</ElementValue>
                <XRef Type="MIM" ID="214100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Zellweger spectrum disorder (ZSD) is a phenotypic continuum ranging from severe to mild. While individual phenotypes (e.g., Zellweger syndrome [ZS], neonatal adrenoleukodystrophy [NALD], and infantile Refsum disease [IRD]) were described in the past before the biochemical and molecular bases of this spectrum were fully determined, the term "ZSD" is now used to refer to all individuals with a defect in one of the ZSD-PEX genes regardless of phenotype. Individuals with ZSD usually come to clinical attention in the newborn period or later in childhood. Affected newborns are hypotonic and feed poorly. They have distinctive facies, congenital malformations (neuronal migration defects associated with neonatal-onset seizures, renal cysts, and bony stippling [chondrodysplasia punctata] of the patella[e] and the long bones), and liver disease that can be severe. Infants with severe ZSD are significantly impaired and typically die during the first year of life, usually having made no developmental progress. Individuals with intermediate/milder ZSD do not have congenital malformations, but rather progressive peroxisome dysfunction variably manifest as sensory loss (secondary to retinal dystrophy and sensorineural hearing loss), neurologic involvement (ataxia, polyneuropathy, and leukodystrophy), liver dysfunction, adrenal insufficiency, and renal oxalate stones. While hypotonia and developmental delays are typical, intellect can be normal. Some have osteopenia; almost all have ameleogenesis imperfecta in the secondary teeth.</Attribute>
                <XRef ID="NBK1448" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301621</ID>
                <ID Source="BookShelf">NBK1448</ID>
              </Citation>
              <XRef ID="C4721541" DB="MedGen" />
              <XRef ID="MONDO:0008953" DB="MONDO" />
              <XRef Type="MIM" ID="214100" DB="OMIM" />
            </Trait>
            <Trait ID="17738" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Refsum disease, infantile form</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Infantile Refsum disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Infantile form of phytanic acid storage disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Peroxisome biogenesis disorder 1B</ElementValue>
                <XRef ID="MONDO:0011101" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PBD1B</ElementValue>
                <XRef Type="MIM" ID="601539" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">IRD</ElementValue>
                <XRef ID="GTR000518899" DB="Genetic Testing Registry (GTR)" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Zellweger spectrum disorder (ZSD) is a phenotypic continuum ranging from severe to mild. While individual phenotypes (e.g., Zellweger syndrome [ZS], neonatal adrenoleukodystrophy [NALD], and infantile Refsum disease [IRD]) were described in the past before the biochemical and molecular bases of this spectrum were fully determined, the term "ZSD" is now used to refer to all individuals with a defect in one of the ZSD-PEX genes regardless of phenotype. Individuals with ZSD usually come to clinical attention in the newborn period or later in childhood. Affected newborns are hypotonic and feed poorly. They have distinctive facies, congenital malformations (neuronal migration defects associated with neonatal-onset seizures, renal cysts, and bony stippling [chondrodysplasia punctata] of the patella[e] and the long bones), and liver disease that can be severe. Infants with severe ZSD are significantly impaired and typically die during the first year of life, usually having made no developmental progress. Individuals with intermediate/milder ZSD do not have congenital malformations, but rather progressive peroxisome dysfunction variably manifest as sensory loss (secondary to retinal dystrophy and sensorineural hearing loss), neurologic involvement (ataxia, polyneuropathy, and leukodystrophy), liver dysfunction, adrenal insufficiency, and renal oxalate stones. While hypotonia and developmental delays are typical, intellect can be normal. Some have osteopenia; almost all have ameleogenesis imperfecta in the secondary teeth.</Attribute>
                <XRef ID="NBK1448" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301621</ID>
                <ID Source="BookShelf">NBK1448</ID>
              </Citation>
              <XRef ID="44" DB="Orphanet" />
              <XRef ID="C0282527" DB="MedGen" />
              <XRef ID="MONDO:0011101" DB="MONDO" />
              <XRef Type="MIM" ID="601539" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
          <TraitSet ID="551" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5138" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Zellweger leukodystrophy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Peroxisome biogenesis disorder 1A (Zellweger)</ElementValue>
                <XRef ID="MONDO:0008953" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Peroxisome biogenesis disorder 1a</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PBD1A</ElementValue>
                <XRef Type="MIM" ID="214100" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CHR</ElementValue>
                <XRef Type="MIM" ID="214100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Zellweger spectrum disorder (ZSD) is a phenotypic continuum ranging from severe to mild. While individual phenotypes (e.g., Zellweger syndrome [ZS], neonatal adrenoleukodystrophy [NALD], and infantile Refsum disease [IRD]) were described in the past before the biochemical and molecular bases of this spectrum were fully determined, the term "ZSD" is now used to refer to all individuals with a defect in one of the ZSD-PEX genes regardless of phenotype. Individuals with ZSD usually come to clinical attention in the newborn period or later in childhood. Affected newborns are hypotonic and feed poorly. They have distinctive facies, congenital malformations (neuronal migration defects associated with neonatal-onset seizures, renal cysts, and bony stippling [chondrodysplasia punctata] of the patella[e] and the long bones), and liver disease that can be severe. Infants with severe ZSD are significantly impaired and typically die during the first year of life, usually having made no developmental progress. Individuals with intermediate/milder ZSD do not have congenital malformations, but rather progressive peroxisome dysfunction variably manifest as sensory loss (secondary to retinal dystrophy and sensorineural hearing loss), neurologic involvement (ataxia, polyneuropathy, and leukodystrophy), liver dysfunction, adrenal insufficiency, and renal oxalate stones. While hypotonia and developmental delays are typical, intellect can be normal. Some have osteopenia; almost all have ameleogenesis imperfecta in the secondary teeth.</Attribute>
                <XRef ID="NBK1448" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301621</ID>
                <ID Source="BookShelf">NBK1448</ID>
              </Citation>
              <XRef ID="C4721541" DB="MedGen" />
              <XRef ID="MONDO:0008953" DB="MONDO" />
              <XRef Type="MIM" ID="214100" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="55427" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="52389" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Zellweger spectrum disorders</ElementValue>
                <XRef ID="MONDO:0019609" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Zellweger Spectrum Disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Zellweger Spectrum</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Zellweger syndrome</ElementValue>
                <XRef ID="912" DB="Orphanet" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ZWS</ElementValue>
                <XRef Type="MIM" ID="214100" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">ZS</ElementValue>
                <XRef Type="MIM" ID="214100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7917" />
                <XRef ID="7917" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2023">
                <URL>https://www.acmg.net/PDFLibrary/X-ALD-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated lysophosphatidylcholines, X-Linked Adrenoleukodystrophy (X-ALD), 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2023">
                <URL>https://www.acmg.net/PDFLibrary/X-ALD-Algorithm.pdf</URL>
                <CitationText>ACMG Algorithm, X-ALD: Elevated lysophosphatidylcholines C24:0, C26:0, 2023</CitationText>
              </Citation>
              <XRef ID="912" DB="Orphanet" />
              <XRef ID="C0043459" DB="MedGen" />
              <XRef ID="MONDO:0019609" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="23229" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5227" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">PEROXISOME BIOGENESIS DISORDER 1C</ElementValue>
                <XRef Type="MIM" ID="234580" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Heimler syndrome 1</ElementValue>
                <XRef ID="MONDO:0024544" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HMLR1</ElementValue>
                <XRef Type="MIM" ID="234580" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PBD1C</ElementValue>
                <XRef Type="MIM" ID="234580" DB="OMIM" />
              </Symbol>
              <XRef ID="3220" DB="Orphanet" />
              <XRef ID="C4551980" DB="MedGen" />
              <XRef Type="MIM" ID="234580" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="7944" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5752" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">PEROXISOME BIOGENESIS DISORDER (NEONATAL ADRENOLEUKODYSTROPHY/INFANTILE REFSUM DISEASE)</ElementValue>
                <XRef Type="MIM" ID="601539" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">INFANTILE PHYTANIC ACID STORAGE DISEASE</ElementValue>
                <XRef Type="MIM" ID="601539" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PEROXISOME BIOGENESIS DISORDER (NALD/IRD)</ElementValue>
                <XRef Type="MIM" ID="601539" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ADRENOLEUKODYSTROPHY, AUTOSOMAL NEONATAL</ElementValue>
                <XRef Type="MIM" ID="601539" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Peroxisome biogenesis disorders, Zellweger syndrome spectrum</ElementValue>
                <XRef ID="Peroxisome+biogenesis+disorders/5684" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Peroxisome biogenesis disorder</ElementValue>
                <XRef ID="INHP_50" DB="Ege University Pediatric Genetics, Ege University" />
                <XRef ID="MONDO:0019234" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS214100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ALD: Adrenoleukodystrophy, X-Linked</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PBDS</ElementValue>
                <XRef ID="GTR000500811" DB="Genetic Testing Registry (GTR)" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">PBD, ZSS</ElementValue>
                <XRef ID="NBK1448" DB="GeneReviews" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Zellweger spectrum disorder (ZSD) is a phenotypic continuum ranging from severe to mild. While individual phenotypes (e.g., Zellweger syndrome [ZS], neonatal adrenoleukodystrophy [NALD], and infantile Refsum disease [IRD]) were described in the past before the biochemical and molecular bases of this spectrum were fully determined, the term "ZSD" is now used to refer to all individuals with a defect in one of the ZSD-PEX genes regardless of phenotype. Individuals with ZSD usually come to clinical attention in the newborn period or later in childhood. Affected newborns are hypotonic and feed poorly. They have distinctive facies, congenital malformations (neuronal migration defects associated with neonatal-onset seizures, renal cysts, and bony stippling [chondrodysplasia punctata] of the patella[e] and the long bones), and liver disease that can be severe. Infants with severe ZSD are significantly impaired and typically die during the first year of life, usually having made no developmental progress. Individuals with intermediate/milder ZSD do not have congenital malformations, but rather progressive peroxisome dysfunction variably manifest as sensory loss (secondary to retinal dystrophy and sensorineural hearing loss), neurologic involvement (ataxia, polyneuropathy, and leukodystrophy), liver dysfunction, adrenal insufficiency, and renal oxalate stones. While hypotonia and developmental delays are typical, intellect can be normal. Some have osteopenia; almost all have ameleogenesis imperfecta in the secondary teeth.</Attribute>
                <XRef ID="NBK1448" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="11890" />
                <XRef ID="11890" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000501629" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501632" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000318883" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000525961" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501647" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000028503" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501630" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000318886" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500811" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501473" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501466" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501635" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592488" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501628" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000070507" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000028499" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000318975" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501625" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501631" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501633" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501474" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501634" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501626" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000593050" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000004880" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501644" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000070509" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501472" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520399" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301621</ID>
                <ID Source="BookShelf">NBK1448</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2023">
                <URL>https://www.acmg.net/PDFLibrary/X-ALD-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated lysophosphatidylcholines, X-Linked Adrenoleukodystrophy (X-ALD), 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2023">
                <URL>https://www.acmg.net/PDFLibrary/X-ALD-Algorithm.pdf</URL>
                <CitationText>ACMG Algorithm, X-ALD: Elevated lysophosphatidylcholines C24:0, C26:0, 2023</CitationText>
              </Citation>
              <XRef ID="79189" DB="Orphanet" />
              <XRef ID="C1832200" DB="MedGen" />
              <XRef ID="MONDO:0019234" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS214100" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2292621" SubmissionDate="2019-09-27" DateLastUpdated="2020-02-29" DateCreated="2020-02-29">
        <ClinVarSubmissionID localKey="NC_000007.13:g.92147046_92147047delTT|OMIM:214100;601539" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001163565" DateUpdated="2020-02-29" DateCreated="2020-02-29" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.92147046_92147047delTT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="214100" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="601539" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>BG_GA_2018_SNVs_INDELS</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2672033" SubmissionDate="2020-03-06" DateLastUpdated="2020-06-22" DateCreated="2020-06-22">
        <ClinVarSubmissionID localKey="NM_000466.2:c.782_783del|MedGen:C1832200" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001363676" DateUpdated="2020-06-22" DateCreated="2020-06-22" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-01-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19105186</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21031596</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23247051</ID>
          </Citation>
          <Comment>Variant summary: The variant, PEX1 c.782_783delAA (p.Gln261ArgfsX8) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (eg. c.2097dupT(p.Ile700fsX42), c.2916delA(p.Gly973fsX16)). The variant allele was found at a frequency of 3.7e-05 in 243912 control chromosomes (gnomAD) and has been reported in the literature in multiple individuals affected with Zellweger syndrome spectrum disorder (ZSS) and Zellweger Syndrome (Ebberink_2010, Yik_2009, Sun_2013) . These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000466.2:c.782_783del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Peroxisome biogenesis disorders, Zellweger syndrome spectrum</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C1832200" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6913290</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4070183" SubmissionDate="2022-02-09" DateLastUpdated="2022-04-23" DateCreated="2022-04-23">
        <ClinVarSubmissionID localKey="NM_000466.3:c.782_783del|Zellweger syndrome" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002079332" DateUpdated="2022-04-23" DateCreated="2022-04-23" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-03-17">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000466.3:c.782_783del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Zellweger syndrome</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10993736</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="397327" SubmissionDate="2015-03-11" DateLastUpdated="2022-12-24" DateCreated="2015-03-29">
        <ClinVarSubmissionID localKey="NM_000466.2(PEX1):c.782_783delAA" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000220571" DateUpdated="2022-12-24" DateCreated="2015-03-29" Type="SCV" Version="2" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-08-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19105186</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23247051</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Counsyl Autosomal and X-linked Recessive Disease Classification criteria (2015)</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rb7nm21v/ar_xl2015criteria.pdf</URL>
            <CitationText>Counsyl Autosomal and X-linked Recessive Disease Classification criteria (2015)</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000466.2:c.782_783delAA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Zellweger syndrome</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="214100" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>Counsyl_2015_03_01</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5050008" SubmissionDate="2022-10-19" DateLastUpdated="2023-03-04" DateCreated="2022-10-22">
        <ClinVarSubmissionID localKey="GDXSV:244059" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002584157" DateUpdated="2023-03-04" DateCreated="2022-10-22" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at a significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 33708531, 19105186, 23247051)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX1" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:674665</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000466.2:c.782_783del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_135_20221019054204</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7857264" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000466.3:c.782_783del|OMIM:234580" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004203269" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000466.3:c.782_783del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="234580" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3966151" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="b604dbfdf99fcd078a6ad35865e296f04bb40cb000133b514d1ce990dddbc90d|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002016575" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000466.3:c.782_783del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1832382" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="2680398|MedGen:C0043459" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000938495" DateUpdated="2024-02-14" DateCreated="2019-08-14" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21031596</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26387595</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31831025</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19105186</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23247051</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Gln261Argfs*8) in the PEX1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PEX1 are known to be pathogenic (PMID: 21031596, 26387595, 31831025). This variant is present in population databases (rs749067142, gnomAD 0.01%). This premature translational stop signal has been observed in individuals with peroxisome biogenesis disorders (PMID: 19105186, 23247051). ClinVar contains an entry for this variant (Variation ID: 188910). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.92147046_92147047del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0043459" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7251058" SubmissionDate="2024-04-20" DateLastUpdated="2024-05-01" DateCreated="2023-04-15">
        <ClinVarSubmissionID localKey="a9147251|MedGen:C0950123" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003903720" DateUpdated="2024-05-01" DateCreated="2023-04-15" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-02-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">2324705</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19105186</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23247051</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">33708531</ID>
          </Citation>
          <Comment>The c.782_783delAA (p.Q261Rfs*8) alteration, located in exon 5 (coding exon 5) of the PEX1 gene, consists of a deletion of 2 nucleotides from position 782 to 783, causing a translational frameshift with a predicted alternate stop codon after 8 amino acids. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Based on data from gnomAD, the c.782_783delAA allele has an overall frequency of 0.004% (9/249146) total alleles studied. The highest observed frequency was 0.013% (4/30214) of South Asian alleles. This variant has been reported compound heterozygous with other PEX1 variants in individuals with features consistent with PEX1-related peroxisome biogenesis spectrum disorder (Yik, 2009; Sun, 2013; Lu, 2021). Based on the available evidence, this alteration is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000466.2:c.782_783delAA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0950123" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>FinalAVA3AVA4ClinvarDepositThrough031523</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava4_2</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5050008" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7251058" TraitType="Disease" MappingType="XRef" MappingValue="C0950123" MappingRef="MedGen">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7857264" TraitType="Disease" MappingType="XRef" MappingValue="234580" MappingRef="OMIM">
        <MedGen CUI="C4551980" Name="Heimler syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2292621" TraitType="Disease" MappingType="XRef" MappingValue="601539" MappingRef="OMIM">
        <MedGen CUI="C0282527" Name="Peroxisome biogenesis disorder 1B" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4070183" TraitType="Disease" MappingType="Name" MappingValue="Zellweger syndrome" MappingRef="Preferred">
        <MedGen CUI="C0043459" Name="Zellweger spectrum disorders" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2672033" TraitType="Disease" MappingType="Name" MappingValue="Peroxisome biogenesis disorders, Zellweger syndrome spectrum" MappingRef="Preferred">
        <MedGen CUI="C1832200" Name="Peroxisome biogenesis disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3966151" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="397327" TraitType="Disease" MappingType="Name" MappingValue="Zellweger syndrome" MappingRef="Preferred">
        <MedGen CUI="C0043459" Name="Zellweger spectrum disorders" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2292621" TraitType="Disease" MappingType="XRef" MappingValue="214100" MappingRef="OMIM">
        <MedGen CUI="C4721541" Name="Peroxisome biogenesis disorder 1A (Zellweger)" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1832382" TraitType="Disease" MappingType="XRef" MappingValue="C0043459" MappingRef="MedGen">
        <MedGen CUI="C0043459" Name="Zellweger spectrum disorders" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

